Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.200 EUR
−204.08 M EUR
154.27 M EUR
142.61 M
About Adaptive Biotechnologies Corporation
Sector
Industry
CEO
Chad Robins
Website
Headquarters
Seattle
Founded
2009
FIGI
BBG00PKDCX25
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange AD.BIOTECH.CORP. DL-,0001 stocks are traded under the ticker 1HM.
We've gathered analysts' opinions on AD.BIOTECH.CORP. DL-,0001 future price: according to them, 1HM price has a max estimate of 9.47 EUR and a min estimate of 5.21 EUR. Watch 1HM chart and read a more detailed AD.BIOTECH.CORP. DL-,0001 stock forecast: see what analysts think of AD.BIOTECH.CORP. DL-,0001 and suggest that you do with its stocks.
Yes, you can track AD.BIOTECH.CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
AD.BIOTECH.CORP. DL-,0001 is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
1HM earnings for the last quarter are −0.20 EUR per share, whereas the estimation was −0.26 EUR resulting in a 23.49% surprise. The estimated earnings for the next quarter are −0.24 EUR per share. See more details about AD.BIOTECH.CORP. DL-,0001 earnings.
AD.BIOTECH.CORP. DL-,0001 revenue for the last quarter amounts to 41.71 M EUR, despite the estimated figure of 36.14 M EUR. In the next quarter, revenue is expected to reach 43.83 M EUR.
1HM net income for the last quarter is −28.80 M EUR, while the quarter before that showed −43.15 M EUR of net income which accounts for 33.25% change. Track more AD.BIOTECH.CORP. DL-,0001 financial stats to get the full picture.
No, 1HM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 709.00 employees. See our rating of the largest employees — is AD.BIOTECH.CORP. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AD.BIOTECH.CORP. DL-,0001 EBITDA is −131.19 M EUR, and current EBITDA margin is −105.34%. See more stats in AD.BIOTECH.CORP. DL-,0001 financial statements.
Like other stocks, 1HM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AD.BIOTECH.CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.